首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2058237

診斷劑市場：按產品類型、應用、最終用戶和地區分類

Diagnostic Reagent Market, By Product Type, By Application, By End User, By Geography

出版日期: 2026年05月28日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，診斷劑市場規模將達到568億美元，到2033年將達到895億美元。預計從2026年到2033年，該市場將以6.7%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	568億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.70%	2033年市場規模預測：	895億美元

全球診斷試劑市場是醫療保健產業的重要組成部分，包括用於疾病檢測和醫學測試的各種化學品、生物物質和免疫物質。

診斷試劑主要用於全球的臨床檢查室、醫院和研究機構。它們在疾病診斷中發揮著至關重要的作用，並支持多種疾病的臨床監測和治療過程。根據所檢測的生物標記、病原體或參數的不同，這些試劑包括臨床化學試劑、免疫檢測試劑、血液學試劑、分子診斷試劑和微生物學試劑。

隨著預測性和個人化醫療在全球日益重要，人們致力於更精準、更早診斷疾病，診斷試劑在慢性病和感染疾病的篩檢和臨床檢測中也變得癒發關鍵。自動化、調查方法和精準醫療的進步不斷提升著科技對診斷試劑研發的影響。此外，已開發國家和開發中國家醫療基礎設施的建設也顯著推動了全球診斷試劑市場的發展。

市場動態

全球診斷劑市場成長的主要驅動力是全球眾多慢性疾病的流行。人口老化也是推動市場成長的重要因素，因為老年人需要更頻繁的檢測，進而導致各細分市場買家數量的增加。分子診斷、自動化和就地檢驗的技術突破正在推動市場發展，與人工檢測相比，這些技術能夠以更低的成本提供更快、更準確的結果，因此吸引了終端用戶的注意。尤其是在新冠疫情爆發後，由於對診斷檢測的迫切需求，市場呈現爆發式成長，診斷劑組分的需求也隨之激增。

然而，該市場也面臨許多挑戰，例如，臨時監管政策導致的核准障礙限制了產業發展，以及先進診斷設備的高昂維修成本。後者又阻礙了開發中國家對這些設備的採用。高昂的維護成本導致診斷劑價格上漲，進而限制了資源匱乏國家（尤其是世界開發中地區）獲得試劑的機會。此外，複雜的儲存和處理要求，包括必須遵守的低溫運輸協議，也進一步加劇了這些挑戰。

儘管面臨諸多挑戰與障礙，新興市場仍被視為極具潛力的市場進入途徑，備受關注。這是因為醫療保健支出的增加正在推動各國醫療基礎設施的建設。此外，該行業的未來無疑一片光明。更個人化的醫療保健和配套診斷工具的開發，以及人工智慧和機器學習在醫療流程自動化中的應用，都為市場帶來巨大的成長潛力。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球診斷劑市場的主要參與者進行了分析：公司亮點、產品系列、主要特點、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球診斷劑市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球診斷劑市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Danaher Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Sysmex Corporation
Qiagen NV
Becton Dickinson（BD）
BioMerieux

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9552

Diagnostic Reagent Market is estimated to be valued at USD 56.8 Bn in 2026 and is expected to reach USD 89.5 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 56.8 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.70%	2033 Value Projection:	USD 89.5 Bn

The global diagnostic reagent market is an integral part of healthcare industry which includes different kinds of chemical, biological, and immunological substance used in disease detection and medical testing.

Diagnostic reagents are mainly used in the clinical laboratories as well as hospitals and research Institutions across the globe. They play a very important role in disease diagnosis and help in the clinical monitoring and the treatment process of a wide array of diseases. These include clinical chemistry reagents, immunoassay reagents, hematology reagents, molecular diagnostics reagents, and microbiology reagents, depending upon the presence of the various biomarkers, pathogens, or parameters.

With the emphasis on predictive, personalized medicine practiced throughout the world for better and early diagnosis of disease, diagnostic reagents are becoming increasingly important for disease screening and laboratory tests for chronic and infectious diseases all over the world. There has been a continued increase in the effect of technology on diagnostics reagents development with various advancements in automation, methodologies, and precision medicine. Also, the increasing rate of development of healthcare infrastructure in developed and developing nations has contributed substantially to the global diagnostic reagent market.

Market Dynamics

The growth of the global diagnostic reagent market is mainly driven by the large number of chronic diseases prevalent across the globe. The aging global population translates into higher number of segment buyers, as the elderly populace demands more frequent tests, probes the market. The technological breakthroughs in molecular diagnostics, automation and point of care testing have attended good positive developments in the market as they deliver more speedy and accurate results at less prices compared to manual testing and procedures, arousing interest among the end consumer. The market has been especially busy post the pandemic outbreak of COVID-19 calls to act decisively on diagnostic testing which led to a proliferation of demand for the components of diagnostic reagents.

However, the market also encounters challenges in the form of application approval hurdles attributable to the transitory regulatory policies, which restrict the growth of the industry and the high maintenance costs of sophisticated diagnostic equipment, which, in turn, hampers their availability in developing nations. The high maintenance costs have implications on the high costs of diagnostics reagents, thereby limiting their accessibility across resource-deficient nations, especially in the developing parts of the world. The challenges also include their complex storage and handling requirements, including the cold chain protocols to be maintained, compounding their difficulties further.

Despite the existing several challenges and hurdles, the emerging markets have been identified to be potential successful grounds for market foray as increasing spend by healthcare caters to the country's developing healthcare infrastructure. The future also certainly looks bright for the industry, during which the avenues of developing tools for more personalized medicine and companion diagnostics for each unique individual, mechanizing the entire process with artificial intelligence and machine learning in the mix offer incredible room for the market to flourish.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diagnostic reagent market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Sysmex Corporation, Qiagen N.V., Becton Dickinson (BD), and BioMerieux
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global diagnostic reagent market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic reagent market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Chemistry Reagents
- Immunodiagnostic Reagents
- Molecular Diagnostic Reagents
- Hematology and Coagulation Reagents
- Others
Application Insights (Revenue, USD Bn, 2021 - 2033)
- Infectious Disease Testing
- Oncology Testing
- Cardiology Testing
- Genetic Testing
- Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Sysmex Corporation
- Qiagen N.V.
- Becton Dickinson (BD)
- BioMerieux

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Diagnostic Reagent Market, By Product Type
- Global Diagnostic Reagent Market, By Application
- Global Diagnostic Reagent Market, By End User
- Global Diagnostic Reagent Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends

4. Global Diagnostic Reagent Market, By Product Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Clinical Chemistry Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Immunodiagnostic Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Molecular Diagnostic Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Hematology and Coagulation Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Diagnostic Reagent Market, By Application, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Oncology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cardiology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Diagnostic Reagent Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Diagnostic Reagent Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton Dickinson (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies